| Year |
Title |
Altmetric |
| 2022
|
A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions.
EMBO Molecular Medicine.
14.
2022
|
|
| 2022
|
Mycobacterium tuberculosis DosS binds H2S through its Fe3+ heme iron to regulate the DosR dormancy regulon.
Redox Biology.
52.
2022
|
|
| 2021
|
Micro-computed tomography analysis of the human tuberculous lung reveals remarkable heterogeneity in three-dimensional granuloma morphology.
American Journal of Respiratory and Critical Care Medicine.
204:583.
2021
|
|
| 2021
|
Mycobacterium tuberculosis h2s functions as a sink to modulate central metabolism, bioenergetics, and drug susceptibility.
Antioxidants.
10.
2021
|
|
| 2021
|
Mycobacterium tuberculosis H2S functions as a sink to modulate central metabolism, bioenergetics, and drug susceptibility
2021
|
|
| 2020
|
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis.
Nature Communications.
11.
2020
|
|
| 2020
|
Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis.
Nature Communications.
11.
2020
|
|
| 2020
|
The Role of Host-Generated H2S in Microbial Pathogenesis: New Perspectives on Tuberculosis.
Frontiers in Cellular and Infection Microbiology.
10.
2020
|
|
| 2019
|
Erratum: Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis (Cell Reports (2018) 25(7) (1938–1952.e5), (S2211124718316772), (10.1016/j.celrep.2018.10.073)).
Cell Reports.
28:3286.
2019
|
|
| 2018
|
Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis.
Cell Reports.
25:1938-1952.e5.
2018
|
|
| 2018
|
Ferritin H deficiency in myeloid compartments dysregulates host energy metabolism and increases susceptibility to Mycobacterium tuberculosis infection.
Frontiers in Immunology.
9.
2018
|
|
| 2016
|
The emerging role of gasotransmitters in the pathogenesis of tuberculosis.
Nitric Oxide: Biology and Chemistry.
59:28-41.
2016
|
|
| 2016
|
Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis.
Cell Reports.
14:572-585.
2016
|
|
| 2014
|
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy.
Viruses.
6:3293-3310.
2014
|
|
| 2013
|
An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer.
PLoS One.
8.
2013
|
|
| 2012
|
Iron sulfur cluster proteins and microbial regulation: Implications for understanding tuberculosis.
Current Opinion in Chemical Biology.
16:45-53.
2012
|
|
| 2010
|
An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.
Virology.
407:196-205.
2010
|
|
| 2010
|
Transduction of brain dopamine neurons by adenoviral vectors is modulated by car expression: Rationale for tropism modified vectors in PD gene therapy.
PLoS One.
5:1-9.
2010
|
|
| 2010
|
Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains.
Journal of Virology.
84:10558-10568.
2010
|
|
| 2009
|
A strategy for adenovirus vector targeting with a secreted single chain antibody.
PLoS One.
4.
2009
|
|
| 2009
|
Crystallization of the head and galectin-like domains of porcine adenovirus isolate NADC-1 fibre.
Acta Crystallographica Section F: Structural Biology Communications.
65:1149-1152.
2009
|
|
| 2009
|
A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.
Vaccine.
27:7116-7124.
2009
|
|
| 2008
|
Enhanced gene delivery to human primary endothelial cells using tropism-modified adenovirus vectors.
Open Gene Therapy Journal.
1:7-11.
2008
|
|
| 2008
|
Localization of the N-Terminus of Minor Coat Protein IIIa in the Adenovirus Capsid.
Journal of Molecular Biology.
383:923-934.
2008
|
|
| 2008
|
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration.
Blood.
112:2353-2359.
2008
|
|
| 2008
|
Characterization of infectivity of knob-modified adenoviral vectors in glioma..
Cancer Biology and Therapy.
7:786-793.
2008
|
|
| 2008
|
Characterization of infectivity of knob-modified adenoviral vectors in glioma.
Cancer Biology and Therapy.
7:788-795.
2008
|
|
| 2007
|
Gene delivery into malignant glioma by infectivity-enhanced adenovirus: In vivo versus in vitro models.
Neuro-Oncology.
9:280-290.
2007
|
|
| 2007
|
A mosaic fiber adenovirus serotype 5 vector containing reovirus σ1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
Clinical Cancer Research.
13:2777-2783.
2007
|
|
| 2007
|
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy.
Journal of Virology.
81:3272-3284.
2007
|
|
| 2007
|
Novel recombinant adenoviral vector that targets the interleukin-13 receptor α2 chain permits effective gene transfer to malignant glioma.
Human gene therapy. Clinical development.
18:118-129.
2007
|
|
| 2006
|
Transductional targeting of adenovirus vectors for gene therapy.
Cancer Gene Therapy.
13:830-844.
2006
|
|
| 2006
|
An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice.
Virology.
350:103-115.
2006
|
|
| 2006
|
Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells
2006
|
|
| 2006
|
An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery
2006
|
|
| 2005
|
A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy
2005
|
|
| 2005
|
In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model.
Journal of Gene Medicine.
7:1517-1525.
2005
|
|
| 2005
|
Reovirus σ1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway.
Biochemical and Biophysical Research Communications.
335:205-214.
2005
|
|
| 2005
|
Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors
2005
|
|
| 2005
|
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
2005
|
|
| 2004
|
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism.
Virology.
324:103-116.
2004
|
|
| 2004
|
Transductional and transcriptional targeting of adenovirus for clinical applications
2004
|
|
| 2003
|
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
Virology.
309:282-293.
2003
|
|
| 2002
|
A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene.
Molecular Cancer Therapeutics.
1:321-328.
2002
|
|
| 2001
|
Differential NF-κB regulation of bcl-x gene expression in hippocampus and basal forebrain in response to hypoxia.
Journal of Neuroscience Research.
64:223-234.
2001
|
|
| 2001
|
Transcriptional regulation of the BCL-X gene by NF-κB is an element of hypoxic responses in the rat brain.
Neurochemical Research.
26:647-659.
2001
|
|
| 2000
|
Identification and characterization of nuclear factor κB binding sites in the murine bcl-x promoter.
Journal of Neurochemistry.
75:1377-1389.
2000
|
|
| 2000
|
NGF-mediated alteration of NF-κB binding activity after partial immunolesions to rat cholinergic basal forebrain neurons.
International Journal of Developmental Neuroscience.
18:455-468.
2000
|
|
| 2000
|
One Path to Cell Death in the Nervous System.
Neurochemical Research.
25:1373-1383.
2000
|
|
| 1994
|
Mutagenesis of the cyclic AMP receptor protein of Escherichia coli: Targeting positions 83, 127 and 128 the cyclic nucleotide binding pocket.
Nucleic Acids Research.
22:2894-2901.
1994
|
|
